Confirmation of the concept that the individuals selected for this study only have an impaired glucose tolerance, circulating insulin levels that range from 4 to 24 μ-units/ml of blood under physiological conditions, did not differ between the placebo and the treatment group. This evidence concerns the gene INS and Impaired glucose tolerance.